(R)-1-[(R)-tert-Butylphosphinoyl]-2-[(R)-1-(diphenylphosphino)ethyl]ferrocene
98%
- Product Code: 37375
CAS:
1221745-90-9
| Molecular Weight: | 502.3500 g./mol | Molecular Formula: | C₂₈H₃₂FeOP₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22666409 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This chemical is primarily used as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed reactions. Its unique structure, combining ferrocene and phosphine groups, allows it to effectively induce chirality in products, making it valuable in the synthesis of enantiomerically pure compounds. It is commonly applied in hydrogenation, hydroformylation, and cross-coupling reactions, where high enantioselectivity is crucial. Its stability and efficiency make it a preferred choice in pharmaceutical and fine chemical industries for producing chiral intermediates and active pharmaceutical ingredients (APIs). Additionally, it is utilized in academic research to develop new catalytic methodologies and explore stereochemical outcomes in organic synthesis.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | £107.48 |
+
-
|
(R)-1-[(R)-tert-Butylphosphinoyl]-2-[(R)-1-(diphenylphosphino)ethyl]ferrocene
This chemical is primarily used as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed reactions. Its unique structure, combining ferrocene and phosphine groups, allows it to effectively induce chirality in products, making it valuable in the synthesis of enantiomerically pure compounds. It is commonly applied in hydrogenation, hydroformylation, and cross-coupling reactions, where high enantioselectivity is crucial. Its stability and efficiency make it a preferred choice in pharmaceutical and fine chemical industries for producing chiral intermediates and active pharmaceutical ingredients (APIs). Additionally, it is utilized in academic research to develop new catalytic methodologies and explore stereochemical outcomes in organic synthesis.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :